Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF430 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CLMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KANSL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GLI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDM13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF733P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC730098 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPTEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FMO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VWA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SBF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR59 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUVBL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL11A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPFIA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on